Intracranial Dural Arteriovenous Fistulas: Classification, Imaging Findings, and Treatment
AJNR 33:1007-1013, Gandhi, D.,et al, 2012
Predicting sites of New Hemorrhage with Amyloid Imaging in Cerebral Amyloid Angiopathy
Neurol 79:320-326, Gurol, M.E.,et al, 2012
Clinical Reasoning: Encephalopathy in a 10-year-old boy
Neurol 79:e12-e18, Rodan, L. & Tein, I., 2012
Progressive Gait Deterioration in Adolescents with Dravet Syndrome
Arch Neurol 69:873-878, Rodda, J.M.,et al, 2012
Immunotherapy-Responsive Chorea as the Presenting Feature of LGI1-Antibody Encephalitis
Neurol 79:195-196, Tofaris,G.K.,et al, 2012
A 21-year old Woman with Multiple Cancers and a New Brain Lesion
Neurol 78:743-749, Schiff,D.,et al, 2012
Therapeutic Devices for Epilepsy
Ann Neurol 71:157-168, Fisher,R.S., 2012
Early Surgical Therapy for Drug-Resistant Temporal Lobe Epilepsy
JAMA 307:922-930,966,985, Engel,J.,et al, 2012
Clinical Reasoning: A 13-year-old Boy Presenting with Dystonia,Myoclonus,and Anxiety
Neurol 78:e72-e76, Blackburn,J.S. and Cirillo,M.L., 2012
Long-lasting Treatment Effect of Rituximab in MuSK Myasthenia
Neurol 78:189-193, Diaz-Manera,J.,et al, 2012
Sporadic Cerebral Amyloid Angiopathy Revisited: Recent Insights Into Pathophysiology and Clinical Spectrum
JNNP 83:124-137, Charidimou,A.,et al, 2012
Risk Factors for Spinal Cord Lesions in Dystonic Cerebral Palsy and Generalised Dystonia
JNNP 83:159-163, Guettard,E.,et al, 2012
Evidence-based Guideline: Antiepileptic Drug Selection for People with HIV/AIDS
Neurol 78:139-145, Birbeck,G.L.,et al, 2012
New Antithrombotic Drugs for Atrial Fibrillation: Caution is Needed
Lancet 379:e24, Bell,S.,et al, 2012
Anticoagulant Loses its Lustre
Lancet 379:301, Mullar,A., 2012
Hospitalization of Psychiatric Disorders Before and After Onset of Unprovoked Seizures/Epilepsy
Neurol 78:396-401, Adelow,C.,et al, 2012
Uncommon Presentation of Intracranial Cryptococcoma in an Immunocompetent Patient
AJNR 33:e26-27, Batista,R. R.,et al, 2012
Incidence and Prevalence of Epilepsy Among Older US Medicare Beneficiaries
Neurol 78:448-453, Faught,E.,et al, 2012
Natalizumab-Associated PML Identified in the Presymptomatic Phase Using MRI Surveillance
Neurol 78:507-508, Blair,N.F.,et al, 2012
Fatal PML Associated with Efalizumab Therapy
Neurol 78:458-467, Schwab,N.,et al, 2012
Intramuscular Versus Intravenous Therapy for Prehospital Status Epilepticus
NEJM 366:591-600,659, Silbergleit,R.,et al, 2012
The Argatroban and Tissue-Type Plasminogen Activator Stroke Study
Stroke 43:770-775,623, Barreto,A.D.,et al, 2012
Cost-Effectiveness of Dabigatran Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation and Prior Stroke or Transient Ischemic Attack
Stroke 43:881-883, Kamel,H.,et al, 2012
Critique of Apixaban Versus Warfarin in Patients with Atrial Fibrillation
Stroke 43:922-923, Nedeltchev,K, 2012
Variable Presentations of Postpartum Angiopathy
Stroke 43:670-676, Fugate,J.E.,et al, 2012
Cerebral Amyloid Angiopathy
eMedicine, Jan, Menon, R.S., 2012
Subclinical Atrial Fibrillation and the Risk of Stroke
NEJM 366:120-129,178, Healey, J.S., et al, 2012
Left Atrial Catheter Ablation and Ischemic Stroke
Stroke 43:265-270, Haeusler, K.G.,et al, 2012
Risk of Stroke After Coronary Artery Bypass Grafting Effect of Age and Comorbidities
Stroke 43:38-43, Merie, C.,et al, 2012
Using Dabigatran in Patients with Stroke A Practical Guide for Clinicians
Stroke 43:271-279, Alberts, M.J.,et al, 2012
Is It All Cerebral Toxoplasmosis?
Lancet 379:286, Mentzer,A.,et al, 2012
Screening Patients with a Family History of Subarachnoid Haemorrhage for Intracranial Aneurysms: Screening Uptake, Patient Characteristics and Outcome
JNNP 83:86-88, Miller, T.D.,et al, 2012
Cortical Pathology in Multiple Sclerosis Patients with Epilepsy: A 3 Year Longitudinal Study
JNNP 83:49-54, Calabrese, M.,et al, 2012
Current Concept of Neuromyelitis Optica (NMO) and NMO Spectrum Disorders
JNNP doi:10.1136/JNNP-2012-302310, Jacob, A.,et al, 2012
Persistent Diffusion-Restricted Lesions in Bevacizumab-Treated Malignant Gliomas are Associated with Improved Survival Compared with Matched Controls
AJNR 33:1763-1770, Mong, S.,et al, 2012
MELAS
MedLink.com, August, Klopstock, T., 2012
Demographic and Clinical Characteristics of Malignant Multiple Sclerosis
Neurol 76:1996-2001, Gholipour, T.,et al, 2011
Intraventricular Hemorrhage
UpToDate, Sept, Cucchiara B.L. and Pacelli, J.P., 2011
Functional Weakness: Clues to Mechanism from the Nature of Onset
JNNP 83:67-69, Stone, J.,et al, 2011
Management and Outcome of CSF-JC Virus PCR-negative PML in a Natalizumab-treated Patient with MS
Neurol 77:2010-2016, Kuhle, J.,et al, 2011
Evidence-based Guideline: Clinical Evaluation and Treatment of Transverse Myelitis
Neurol 77:2128-2134, Scott, T.F.,et al, 2011
Cancer Risk Among Patients with Myotonic Muscular Dystrophy
JAMA 306:2480-2486, Gadalla, S.M.,et al, 2011
Epstein-Barr Virus Infections of the Nervous System
www.medlink.com, Nov, Amlie-Lefond,C., 2011
Cortical Restricted Diffusion as the Predominant MRI Finding in Sporadic Creutzfeldt-Jakob Disease
Acta Radiologica 52:336-339, Talbott,S.D.,et al, 2011
Non-steroidal anti-inflammatory drug use and risk of atrial fibrillation or flutter: population based case-control study
BMJ 343:d3450, Schmidt, M.,et al, 2011
Headache in Transplant Patients
www.medlink.com, Aug, Lai, T.H., 2011
Autoimmune Encephalopathy
Semin Neurol 31:144-157, Flanagan, E.,et al, 2011
Vertebral Artery Dissection
In, Pathology and surgery around the vertebral artery, Chp 11, p109, Springer, Arnold, M.,et al, 2011
Severe Herpes Simplex Virus Type-I Infections after Dental Procedures
Med Oral Patol Oral Cir Bucal 16:e15-e18, El Hayderi, L.,et al, 2011
Mucormycosis in Immunocompetent Patients: A Case-Series of Patients with Maxillary Sinus Involvement and a Critical Review of the Literature
Int J Inf Dis 15:e533-e540, Mignogna, M.D.,et al, 2011